Tevogen Inc.
No trades
No trades
Compare with Tevogen Inc.
−5.83 USD
−26.28 M USD
0.00 USD
948.21 K
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Ryan Saadi
Website
Headquarters
Warren
Founded
2021
ISIN
US88165K2006
CUSIP
88165K200
FIGI
BBG013395405
Identifiers
ISIN US88165K2006
Tevogen, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of TVGN is 7.81 USD — it has increased by 1.30% in the past 24 hours. Watch Tevogen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tevogen Inc. stocks are traded under the ticker TVGN.
TVGN stock has risen by 12.05% compared to the previous week, the month change is a 20.15% rise, over the last year Tevogen Inc. has showed a −81.84% decrease.
TVGN reached its all-time high on Feb 15, 2024 with the price of 1,054.50 USD, and its all-time low was 3.64 USD and was reached on Jul 20, 2026. View more price dynamics on TVGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TVGN stock is 5.11% volatile and has beta coefficient of 2.61. Track Tevogen Inc. stock price on the chart and check out the list of the most volatile stocks — is Tevogen Inc. there?
Today Tevogen Inc. has the market capitalization of 50.86 M, it has increased by 7.01% over the last week.
Yes, you can track Tevogen Inc. financials in yearly and quarterly reports right on TradingView.
Tevogen Inc. is going to release the next earnings report on Nov 24, 2026. Keep track of upcoming events with our Earnings Calendar.
TVGN net income for the last quarter is −5.76 M USD, while the quarter before that showed −5.45 M USD of net income which accounts for 0.00% change. Track more Tevogen Inc. financial stats to get the full picture.
No, TVGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2026, the company has 18 employees. See our rating of the largest employees — is Tevogen Inc. on this list?
Like other stocks, TVGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tevogen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tevogen Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tevogen Inc. stock shows the sell signal. See more of Tevogen Inc. technicals for a more comprehensive analysis.
